MedTrace Logo

Vapocoolant (Pain Ease Medium Stream) for Intravenous Lines in Emergency Department Patients

NCT01670487 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2025-10-27

Study results available
· View outcomes & findings →

Summary

To determine the efficacy and safety of vapocoolant stream (Pain Ease Medium Stream ) in decreasing the pain of intravenous cannulation.

To compare vapocoolant stream (Pain Ease medium Stream) with control (e.g. sterile water) stream.

Conditions

Interventions

DEVICE

Vapocoolant

Topical stream of 4 to 10 seconds duration to skin

DEVICE

Sterile water

Topical intervention of sterile water stream 4 to 10 seconds to skin.

Sponsors & Collaborators

  • Gebauer Company

    collaborator NETWORK

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Sharon E. Mace, M.D. · The Cleveland Clinic

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-11-30
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01670487 on ClinicalTrials.gov